OSG
Octave Specialty Group, Inc.
NYSE · Financial Services · Insurance - Specialty · US
$4.62
−0.86%Year over year
Reported trailing growth
- Revenue
- +212.8%
- EBITDA
- +86.8%
- EBIT
- +34.9%
- EPS
- +75.9%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- -72.5%
- EBITDA
- +482.1%
- EPS
- +112.5%
Three-year CAGR
- Revenue
- +67.3%
- EBITDA
- -32.4%
- EBIT
- -68.8%
- Net income
- +56.7%
- EPS
- +50.0%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026